Financial Ratios

ADVANCED ENZYME TECHNOLOGIES LTD.

NSE : ADVENZYMESBSE : 540025ISIN CODE : INE837H01020Industry : Pharmaceuticals & DrugsHouse : Private
BSE360.000.8 (+0.22 %)
PREV CLOSE ( ) 359.20
OPEN PRICE ( ) 361.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3223
TODAY'S LOW / HIGH ( )353.70 362.60
52 WK LOW / HIGH ( )249.05 425.1
NSE359.750.35 (+0.1 %)
PREV CLOSE( ) 359.40
OPEN PRICE ( ) 358.55
BID PRICE (QTY) 359.75 (120)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 131203
TODAY'S LOW / HIGH( ) 352.55 362.50
52 WK LOW / HIGH ( )249.25 425.15
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)4.974.886.365.193.16
   CEPS(Rs)5.895.737.165.983.92
   DPS(Rs)5.001.000.900.600.60
   Book NAV/Share(Rs)46.9842.9138.7432.8528.30
   Tax Rate(%)25.2424.3727.8523.6025.36
Margin Ratios
   Core EBITDA Margin(%)24.0426.5935.0331.1123.81
   EBIT Margin(%)23.8926.4134.2731.1822.48
   Pre Tax Margin(%)23.7826.3134.1930.6621.25
   PAT Margin (%)17.7819.9024.6623.4315.86
   Cash Profit Margin (%)21.0723.3927.7926.9919.72
Performance Ratios
   ROA(%)10.0510.7015.5714.519.41
   ROE(%)11.0511.9517.7616.9811.70
   ROCE(%)14.8315.7824.1621.4514.85
   Asset Turnover(x)0.570.540.630.620.59
   Sales/Fixed Asset(x)1.611.531.721.761.88
   Working Capital/Sales(x)2.051.952.422.763.88
Efficiency Ratios
   Fixed Capital/Sales(x)0.620.650.580.570.53
   Receivable days67.6369.1867.5966.4263.05
   Inventory Days91.6595.6278.0187.2593.25
   Payable days57.0078.7168.6760.2478.21
Valuation Parameters
   PER(x)46.6557.8654.2627.5957.96
   PCE(x)39.3649.2248.1523.9446.63
   Price/Book(x)4.936.578.904.366.46
   Yield(%)2.160.350.260.420.33
   EV/Net Sales(x)8.2411.5013.596.499.28
   EV/Core EBITDA(x)30.2238.2935.7818.6835.24
   EV/EBIT(x)34.3943.3539.0420.8141.28
   EV/CE(x)4.465.927.873.805.48
   M Cap / Sales8.3211.5613.596.469.19
Growth Ratio
   Net Sales Growth(%)14.20-3.7714.6011.374.73
   Core EBITDA Growth(%)3.65-23.9325.2646.966.30
   EBIT Growth(%)3.13-26.6827.9054.525.75
   PAT Growth(%)1.86-23.2422.5364.49-1.83
   EPS Growth(%)1.84-23.2822.4764.44-1.84
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.030.06
   Current Ratio(x)5.134.873.903.522.27
   Quick Ratio(x)3.042.662.361.840.97
   Interest Cover(x)226.08265.97414.5659.7118.34
   Total Debt/Mcap(x)0.000.010.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.